| Literature DB >> 34918653 |
Musa Zengin1, Gulay Ulger, Ramazan Baldemir, Hilal Sazak, Ali Alagoz.
Abstract
ABSTRACT: Postoperative efficacy of thoracic epidural analgesia (TEA) following thoracic surgery may vary in patients with different body mass index (BMI) values, regardless of the success of the method. This study aimed to investigate the effects of BMI on postoperative pain scores in patients who underwent thoracotomy with TEA.After obtaining the ethical committee approval (Date: May 11, 2021, Number: 2012-KEAK-15/2305) the data of 1326 patients, who underwent elective thoracic surgery in high volume tertiary thoracic surgery center between January 2017 and January 2021, were analyzed retrospectively. Patients between the age of 18 and 80 years, who underwent thoracotomy and thoracic epidural catheterization (TEC), and who were assigned American Society of Anesthesiologists I to III physical status were included to the study. Of the 406 patients, who underwent a successful TEC, 378 received postoperative analgesia for 72 hours. Visual analog scale (VAS) scores of these patients were evaluated statistically. Based on BMI, patients were categorized into the following 5 groups: Group I: BMI < 20 kg/m2, Group II: BMI = 20 to 24.9 kg/m2, Group III: BMI = 25 to 29.9 kg/m2, Group IV: BMI = 30 to 34.9 kg/m2, and Group V: BMI ≥ 35 kg/m2.There were no statistically significant differences in TEC success across different BMI groups (P > .05). Catheter problems and VAS scores significantly increased with higher BMI values in the postoperative 72-hours period (P < .05). Rates of rescue analgesic use were higher in BMI groups of 30 toto 34.9 kg/m2 and ≥35 kg/m2 compared to the other BMI groups.This study revealed that higher BMI in patients may increase VAS scores, who administered TEA for pain management following thoracotomy. This correlation was supported by the increased need for additional analgesics in patients with high BMI. Therefore, patients with high BMI values would require close monitoring and follow-up.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34918653 PMCID: PMC8677892 DOI: 10.1097/MD.0000000000028010
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.889
Figure 1Patient flowchart. BMI = body mass index, TEC = thoracic epidural catheterization, VAS = visual analog scale.
Demographic characteristics of patients.
| n = 437 Mean ± SD | % Median (IQR) | |
| ASA | ||
| II | 239 | 54.7 |
| III | 198 | 45.3 |
| Age (yrs) | 53.3 ± 14.4 | 56.0 (45.5-64.0) |
| Gender | ||
| Women | 102 | 23.3 |
| Men | 335 | 76.7 |
| BMI | 25.8 ± 4.5 | 26.0 (23.0-28.0) |
| Group I: <20 kg/m2 | 26 | 6 |
| Group II: 20-24.9 kg/m2 | 171 | 39.1 |
| Group III: 25-29.9 kg/m2 | 154 | 35.2 |
| Group IV: 30-34.9 kg/m2 | 64 | 14.7 |
| Group V: ≥35 kg/m2 | 22 | 5.0 |
| Type of surgery | ||
| Segmentectomy, lobectomy | 334 | 76.4 |
| Pneumonectomy | 57 | 13.0 |
| Total decortication | 30 | 6.9 |
| Hydatid cyst, cystectomy | 16 | 3.7 |
| Duration of surgery (min) | 240.4 ± 32.3 | 235.0 (215.0-255.0) |
Data were presented as mean ± standard deviation and percentage/median interquartile range.
ASA = American Society of Anesthesiologists, BMI = body mass index, IQR = interquartile range, TEC = thoracic epidural catheterization.
Thoracic epidural catheterization success by body mass index groups.
| TEC | Group I (n = 26) | Group II (n = 171) | Group III (n = 154) | Group IV (n = 64) | Group V (n = 22) |
|
| Success | 25 (96.2%) | 160 (93.6%) | 139 (90.3%) | 61 (95.3%) | 21 (95.5%) | .567 |
| Failure | 1 (3.8%) | 11 (6.4%) | 15 (9.7%) | 3 (4.7%) | 1 (4.5%) |
TEC = thoracic epidural catheterization.
Chi-Square test (n/%).
Distribution of catheter problems across body mass index groups within the postoperative 72-h period.
| TEC was performed | Group I (n = 25) | Group II (n = 160) | Group III (n = 139) | Group IV (n = 61) | Group V (n = 21) |
| Difference |
| Catheter problems | 1 (4%) | 7 (4.4%) | 8 (5.8%) | 8 (13.1%) | 4 (19.0%) | .030 | † |
TEC = Thoracic epidural catheterization.
Chi-Square test (n/%).
IV-V vs I-II-III.
Visual analog scale scores of patients by body mass index.
| VAS | Group I (n = 24) | Group II (n = 153) | Group III (n = 131) | Group IV (n = 53) | Group V (n = 17) |
| Difference |
| 30th min | 3.1 ± 0.9 | 3.3 ± 1.1 | 3.8 ± 1.3 | 4.9 ± 1.0 | 5.9 ± 1.1 |
| † |
| 1st h | 2.8 ± 0.7 | 2.9 ± 0.9 | 3.3 ± 1.2 | 4.4 ± 1.1 | 5.5 ± 1.1 |
| ‡ , § , || |
| 6th h | 2.5 ± 0.5 | 2.6 ± 0.8 | 3.0 ± 1.1 | 3.7 ± 1.1 | 4.6 ± 1.1 |
| § , || |
| 12th h | 2.4 ± 0.5 | 2.3 ± 0.8 | 2.6 ± 1.0 | 3.0 ± 1.0 | 3.7 ± 0.8 |
| § , || |
| 24th h | 1.8 ± 0.6 | 1.9 ± 0.7 | 2.1 ± 1.0 | 2.4 ± 1.1 | 2.8 ± 0.9 |
| ¶ , # |
| 48th h | 1.4 ± 0.5 | 1.5 ± 0.6 | 1.6 ± 0.9 | 1.9 ± 1.0 | 2.2 ± 0.7 |
| # , ∗∗ |
| 72nd h | 1.0 ± 0.4 | 1.2 ± 0.6 | 1.3 ± 0.8 | 1.5 ± 1.0 | 1.7 ± 0.6 |
| †† |
VAS = visual analog scale.
One-Way ANOVA (Mean ± SD).
All but I-II.
II vs III.
IV vs others.
V vs others.
IV vs I-II.
V vs I-II-III.
IV vs II.
I-II vs IV-V.
Figure 2VAS scores of patients in the postoperative 72-h period, VAS = visual analog scale.
Patients’ need for rescue analgesia by body mass index.
| Group I (n = 24) | Group II (n = 153) | Group III (n = 131) | Group IV (n = 53) | Group V (n = 17) |
| Difference | ||
| Rescue Analgesia | No | 22 (91.7%) | 137 (89.5%) | 97 (74.0%) | 17 (32.1%) | 1 (5.9%) | <.001 | † , ‡ |
| Yes | 2 (8.3%) | 16 (10.5%) | 34 (26.0%) | 36 (67.9%) | 16 (94.1%) |
Chi-Square Test (n/%).
III vs I-II.
IV-V vs I-II-III.
Patient satisfaction by body mass index.
| Group I (n = 24) | Group II (n = 153) | Group III (n = 131) | Group IV (n = 53) | Group V (n = 17) |
| Difference | |
| Not satisfied† | – | 1 (0.7%) | – | – | – | <.001 | ‡ |
| Moderately satisfied | 1 (4.2%) | 9 (5.9%) | 32 (24.4%) | 30 (56.6%) | 14 (82.4%) | ||
| Satisfied | 23 (95.8%) | 143 (93.4%) | 99 (75.6%) | 23 (43.4%) | 3 (17.6%) |
Chi-Square test (n/%).
The groups “I am not satisfied” and “I am moderately satisfied” were combined for intergroup comparisons.
All but I-II.
Distribution of complications by body mass index.
| Group I (n = 24) | Group II (n = 153) | Group III (n = 131) | Group IV (n = 53) | Group V (n = 17) |
| Difference | |
| Headache | |||||||
| No | 21 (87.5%) | 143 (93.5%) | 123 (93.9%) | 52 (98.1%) | 17 (100%) | .324 | – |
| Yes | 3 (12.5%) | 10 (6.5%) | 8 (6.1%) | 1 (1.9%) | – | ||
| Nausea–vomiting | |||||||
| No | 20 (83.3%) | 135 (88.2%) | 108 (82.4%) | 46 (86.8%) | 16 (94.1%) | .540 | – |
| Yes | 4 (16.7%) | 18 (11.8%) | 23 (17.6%) | 7 (13.2%) | 1 (5.9%) | ||
| Hypotension | |||||||
| No | 20 (83.3%) | 122 (79.7%) | 109 (83.2%) | 46 (86.8%) | 15 (88.2%) | .740 | – |
| Yes | 4 (16.7%) | 31 (20.3%) | 22 (16.8%) | 7 (13.2%) | 2 (11.8%) | ||
| Pruritus | |||||||
| No | 23 (95.8%) | 140 (91.5%) | 125 (95.4%) | 47 (88.7%) | 17 (100%) | .301 | – |
| Yes | 1 (4.2%) | 13 (8.5%) | 6 (4.6%) | 6 (11.3%) | – | ||
| Sweating | |||||||
| No | 24 (100%) | 151 (98.7%) | 126 (96.2%) | 51 (96.2%) | 17 (100%) | .499 | – |
| Yes | – | 2 (1.3%) | 5 (3.8%) | 2 (3.8%) | – | ||
| Bradycardia | |||||||
| No | 24 (100%) | 150 (98.0%) | 128 (97.7%) | 53 (100%) | 17 (100%) | .723 | – |
| Yes | – | 3 (2.0%) | 3 (2.3%) | – | – | ||
| Respiratory arrest | |||||||
| No | 24 (100%) | 153 (100%) | 131 (100%) | 53 (100%) | 17 (100%) | 1.000 | – |
| Yes | (0.0%) | (0.0%) | (0.0%) | (0.0%) | (0.0%) | ||
Chi-Square test (n/%).